Dry Needling and Functional Improvement
Does Site-specific Trigger Point Dry Needling Evoke Segmental Neuromodulation in the Lower Extremity and if so, do These Changes Make an Impact on the Subject's Disability?
Sponsor: Brigham Young University
A NA clinical study on Myofascial Pain Syndrome and Myofascial Trigger Point Pain, this trial is terminated or withdrawn. The trial is conducted by Brigham Young University and has accumulated 8 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
May 2024 — Jul 2024 [monthly]
Terminated NA
Status: Unknown Status → Terminated
-
Jan 2021 — May 2024 [monthly]
Unknown Status NA
-
Feb 2020 — Jan 2021 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
▶ Show 3 earlier versions
-
Jun 2018 — Feb 2020 [monthly]
Recruiting NA
-
Feb 2018 — Jun 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jan 2017 — Feb 2018 [monthly]
Not Yet Recruiting NA
First recorded
Dec 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Brigham Young University
For direct contact, visit the study record on ClinicalTrials.gov .